Description：Rabbit polyclonal antibody to p16 INK4aImmunogen：KLH-conjugated synthetic peptide encompassing a sequence within the N-term region of human p16 INK4a. The exact sequence is proprietary.Purification：The antibody was purified by immunogen affinity chromatography.Clonality：PolyclonalForm：Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.Dilution：WB (1/500 - 1/1000), IH (1/50 - 1/100)Gene Symbol：CDKN2AAlternative Names：CDKN2; MTS1; Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3; Cyclin-dependent kinase 4 inhibitor A; CDK4I; Multiple tumor suppressor 1; MTS-1; p16-INK4a; p16-INK4; p16INK4A Entrez Gene (Human)： 1029; Entrez Gene (Mouse)： 12578; Entrez Gene (Rat)： 25163; SwissProt (Human)： P42771; SwissProt (Mouse)： P51480; SwissProt (Rat)： Q9R0Z3; Storage/Stability：Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.

• 
  Western blot analysis of p16 INK4a expression in HEK293T (A), HeLa (B), mouse brain (C), rat brain (D) whole cell lysates. (Predicted band size: 16 kD; Observed band size: 20 kD )
• 
  Immunohistochemical analysis of p16 INK4a staining in human colorectal cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.